While gemcitabine treatment induced a 28% decrease in the number of tumor cells expressing high CA IX compared to vehicle-treated tumors, the CA IX inhibition by the combination of gemcitabine with LX2931 was much stronger (around 61%). This evidence concerns the gene CA9 and neoplasm.